As part of a larger study of the plants used by the Garifuna of eastern Nicaragua, the 229 species representing 177 genera and 72 families used for medicinal purposes were assayed for the presence of bioactive compounds. A review of the literature for alkaloids and glycosides showed that 113 species contained at least one of these bioactive compounds. The remaining 116 species not previously cited were tested for alkaloids with Dragendorff's reagent; 51 contained alkaloids. The combined results show that 72% of the species the Garifuna use medicinally have at least one alkaloid or glycoside. Tests to explore pharmacological activity of compounds from selected species represent the next step to determining efficacy and application of these medicinals.
Introduction
Medicinal plants are the oldest source of pharmacologically active compounds and provided virtually the only source of medicinally useful compounds for centuries (Cordell, 1981) . Today it is estimated that more than two-thirds of the world's population relies on plant-derived drugs; some 7000 medicinal compounds used in the Western pharmacopoeia are derived from plants (Caufield, 1991) . In the USA, approximately 25% of all prescription drugs used contain one or more bioactive compounds derived from vascular plants * Corresponding author. (Farnsworth and Morris, 1976; Farnsworth, 1984a) .
Few new drugs are being developed from wild sources such as tropical forests because of the high cost and the rigid requirements for their development (Tyler et al., 1988; Principe, 1992) . However, no matter how high the dollar cost may be, the loss of the potential for discovery of new treatments for serious human ailments is even greater. The annual rate of tropical deforestation is estimated at 8-11 million hectares (Myers, 1984 (Myers, , 1985 . Predictions are that by the year 2050 as many as 25% of tropical plant species will be extinct (Lucas, 1978; IUCN, 1986; Caufield, 1991; Raven, 1988) . The destruction of tropical rainforests in eastern Nicaragua, as elsewhere in the world, is rampant. By the year 2000, Nicaragua may have lost more than 50°,6 of its 1981 rainforest (Caufield, 1991) . With this loss goes the opportunity for discovery of new drug plants. The loss of habitat and the extinction of species in tropical forests is disturbingly rapid, but ethnobotanical information is being lost at an even faster rate. With the diminution, dilution or decimation of traditional plant-use practices goes the opportunity to apply knowledge accumulated during hundreds of generations of human empirical testing of bioactive compounds.
Many pharmaceuticals we use today are of botanical origin and are based on herbal remedies from the folk medicine of native peoples (Tyler et al., 1988) . Schultes (1986) suggests that the most important drugs of the past 50 years or so were first isolated from plants used ethnomedically. In fact, 74% of the 119 biologically active plantderived compounds at present used worldwide were discovered as a result of research on species first identified in ethnobotanical surveys (Farnsworth and Soejarto, 1985; Farnsworth, 1988) . Thus, phytochemical screening of plant species of ethnopharmacological use will provide valuable baseline information in the search for new pharmaceuticals. Yet fewer than 10% of tropical plants species have been examined for the presence of bioactive compounds (Myers, 1984) .
The pharmacopoeia of the Garifuna of eastern Nicaragua consists of 229 species representing 177 genera and 72 families of vascular plants (Table 1) . From these medicinals several hundred remedies are prepared that are used in treating more than 30 human ailments (Coe and Anderson, 1996) . The objectives of this study were to survey the literature for alkaloids and glycosides of these 229 species, and to run assays for alkaloids on those not reported. These results are then used to consider the efficacy of these medicinals, and we hope they may lead to more detailed phytochemical and pharmacological analyses.
The people
The Garifuna are descendants of Red Carib Islanders and African slaves (Davidson, 1976 (Davidson, , 1980 Crawford, 1984) . They are relative newcomers to the Atlantic Coast of Nicaragua. They arrived in eastern Nicaragua ca. 1890 to work in the extraction of timber (mahogany) around the Pearl Lagoon in eastern Nicaragua (Hale and Gordon, 1987) . The Garifuna communities in the Pearl Lagoon area of Nicaragua (Fig. 1) were founded around the turn of the century (Davidson, 1976 (Davidson, , 1980 , and are the southernmost site of Garifuna culture. At present there are about 1500 Garifuna living on the Atlantic Coast of Nicaragua (Davidson, 1980; Hale and Gordon, 1987) . Most of the Garifuna live in four small villages (Justo Point, La Fr, Marshall Point, and Orinoco), all on the southwest rim of the Pearl Lagoon (Fig. 1) . One of the authors has observed that the largest of these settlements is Orinoco with a population of 650, in nearly 100 dwellings (see also Davidson, 1980) . The Garifuna practice slashand-burn agriculture on small plantations of 1-2 ha. in size. Their major sources of income are agriculture and logging, with fishing and hunting done seasonally. They participate in the local market economy, selling some of their goods in regional markets.
Study area
Nicaragua is the largest of the Central American republics. It encompasses about 140 000 km 2, of which 41 700 km 2 is tropical forest (Sutton, 1989) . The Eastern Lowlands of Nicaragua are the most extensive landform in the country, making up about one third (41 000 km 2) of the national territory. These lowlands run from sea level to an elevation of 200 m. The eastern lowlands have a tropical climate (25-30°C), with a rainy season of 6-8 months. Climatic factors combine to yield a rainforest (average annual rainfall: 3810 ram), the most extensive in Central America.
Due to the density of the rainforest, abundance of rainfall, and regular distribution of rivers, the east coast of Nicaragua remained essentially undeveloped and isolated from the rest of the country until roads were built recently. The primary means of transportation in the eastern lowlands is still by boat or airplane. The largest city is Bluefields (Fig. 1) around the Garifuna settlements in the Pearl Lagoon area is lowland swamp forest (Sutton, 1989) characterized by the abundance of mangroves and palms along the shore of the lagoon and river banks.
Materials and methods
Interviews of practitioners (shamans, midwives, and others) were conducted and plants were collected for a period of several months in 1992-1993, around the Pearl Lagoon and other settlements along the Wawashan River of eastern Nicaragua (Fig. 1) . Further details about this study and the practitioners are published elsewhere (Coe and Anderson, 1996) . Voucher specimens were prepared and deposited at the Herbarium of the Atlantic Coast of Nicaragua in Bluefields (established by Coe in 1992) , the Missouri Botanical Garden (MO), and the Univer-sity of Connecticut (CONN). The 229 Garifuna medicinals (Table 1) were surveyed for alkaloids and glycosides. This was determined by doing a literature search, covering the period of 1950-1994, of major compendia, including manual and electronic sources on alkaloids (Karrer, 1958 (Karrer, , 1977 (Karrer, , 1981 (Karrer, , 1985 Willaman and Schubert, 1961; Hegnauer, 1962 Hegnauer, , 1963 Hegnauer, , 1964 Hegnauer, , 1966 Hegnauer, , 1969 Hegnauer, , 1973 Hegnauer, , 1986 Hegnauer, , 1989 Hegnauer, , 1990 Hegnauer, , 1992 Hegnauer, , 1994 Willarnan and HuiLin Li, 1970) ; Chemical Abstracts Services (CAS); and Natural Products Alert (NAPRALERT).
The 116 Garifuna medicinals tested for alkaloids are those species not reported in the literature. Plant parts tested are the same as those used in the preparation of herbal remedies, and included both aerial and underground parts (Table 1) . Plant materials were obtained from mature individuals in flower or fruit, and collected and processed according to standard practices (Lawrence, 1951; Bridson and Forman, 1992; Soejarto, 1993; Soejarto et al., 1996) . Alkaloid tests were done in the same way in the field and in the laboratory, using Dragendorff's reagent (Harborne, 1988; Stermitz et al., 1989 ) and thin-layer chromatography (TLC) (Stahl, 1969; Stermitz et al., 1989) .
Alkaloids were determined qualitatively by macerating 10-15 mg of plant material in a test tube in 1-2 ml of 1 M Na2CO 3. Once macerated, 0.5-1.0 ml of 2:1 CHCI3-MeOH was added. The mixture was then mixed with a stirring rod for 3-5 min, then allowed to stand and separate into two phases. The lower phase containing the plant extract in CHC13 was drawn off with a disposable pipet into a depression in a spot plate. The CHCI3 was allowed to evaporate to about a drop (0.025 ml). This amount was spotted on an aluminumbacked TLC strip 10 mm x 40 mm in size. The strips were developed in CHCI3 and alkaloids were visualized (color ranges are yellow/orange, red/orange, red/black, pink, and even purple depending on the species or genus) by spraying with Dragendorff's reagent. Alkaloids were considered present in a plant part when at least two of three replicates gave positive results; number of spots on the TLC strip was not recorded. Since field alkaloid tests can sometimes produce falsepositive reactions, especially in latex-bearing families, e.g. Apocynaceae, Asclepiadaceae, and Moraceae (Farnsworth, 1966) , test results, as applicable, for the above families were verified with reports in the literature. However, the method (Stermitz et al., 1989) used includes a purification procedure (adding a base --Na2CO3 --and extraction with a water immiscible organic solvent --CHCI3) that helps avoid false-positive reactions. Glycoside tests were not done because of time constraints and the complexity of the testing procedure.
Results and discussion
More than 250 plant species are important to the Gafifuna as sources of food, fiber, construction and craft materials, and medicine (Coe and Anderson, 1996) . Medicinal plant species constitute by far the largest use category (Table 1) . Among the 229 medicinal species, 113 contain at least one alkaloid or glycoside reported in the literature (Table 2) . Of the remaining 116 species, 51 species, representing 45 genera and 25 families, tested positive for alkaloids (Table 2) . Thus, 152 species of the Garifuna medicinals contain alkaloids and an additional 12 contain glycosides (Table 2) . About one-half (43%) of alkaloidbearing species are herbs, and about one-third (28%) are trees (Table 3) .
The Fabaceae had the highest number (20) of species with alkaloids (Table 4) . As this would lead one to expect, this family contains many medicinals that are highly regarded by Ga/'ifuna healers (Coe and Anderson, 1996) . Several other families also have a number of genera and species used medicinally that possess alkaloids (e.g. Euphorbiaceae, Rubiaceae, Solanaceae) (Table 4) . In most families where a number of species are utilized, one genus or species tends to predominate. For instance, the following are the dominant genera in some of the most important families: Cassia (Fabaceae), Psychotria (Rubiaceae), Jatropha (Euphorbiaceae), Piper (Piperaceae), and Solanum (Solanaceae). In spite of the prominence of some families and genera, the general pattern we observed was a wide taxonomic distribution of medicinals (Table 4) .
Overall, the results show that the vast majority .=.
Q;
.J~ of the 229 Garifuna medicinal plants contain bioactive compounds. Another sub-sample of the entire list also makes this point. The most commonly used 15 medicinal plant families include some 125 species; more than three-quarters of these species contain alkaloids (Table 4) . Cox et al. (1989) and Farnsworth (1984a Farnsworth ( , 1984b ) also report a strong correlation between medicinal plant use and their bioactive compounds. To make this point even clearer, the most popular medicinal species in the Garifuna pharmacopoeia was analyzed. As Table 5 shows, all these 13 'most popular' species (representing 11 families) tested positive for alkaloids. In fact, they have presumably been recognized in other studies, because all but two were already reported in the literature as alkaloid bearing. Another way of making this point is a comparison of the 25 most popular medicinal species with the 25 that are least used (Table 6 ). This is obviously a subjective ranking, but telling nonetheless. More than 95% of the popular medicinals (24/25) bear alkaloids or glycosides, compared with only 68% (17/25) of the less popular species (this difference is highly significant;/X/2 = 4.878; P = 0.027). The Garifuna are not alone in claiming the healing properties of certain medicinals. For example, Momordica charantia (plant no. 65 in Table 1 ) is also the most popular medicinal among the Miskitu, Sumu, and Rama of eastern Nicaragua. It is also widely used in Mexico, Belize, Honduras, Costa Rica, Panama and the Caribbean (Duke, 1972 (Duke, , 1994 Morton, 1981; Martinez, 1991; Garcia, 1992; Balick and Arvigo, 1993; Duke and Vasquez, 1994) . In China, M. charantia is used to treat more than 10 ailments (Yang and Waiters, 1992) . In Fiji (Cambie and Ash, 1994) and in Sri Lanka (Tennekoon et al., 1994) it is used to treat diabetes. Cassia occidentalis (plant no. 86 in Table 1 ) is another popular medicinal used by the Garifuna and other indigenous groups of both the Old World and New World tropics. In the New World, this species is widely used from Mexico to Colombia and in the Caribbean (Duke, 1972 (Duke, , 1994 Morton, 1981; Martinez, 1991; Garcia, 1992; Balick and Arvigo, 1993; Duke and Vasquez, 1994) . In Fiji, C. occidentalis is used as a pediatric anticonvulsive and sedative (Cambie and Ash, 1994) . This species is also used medicinally in the Philippines, China, and Guam (Perry, 1980; Concha, 1982) . In F. G. Coe, G.J. Anderson / Journal of Ethnopharmacolog y 53 (1996) Thailand, C occidentalis is used to treat malaria, digestive disorders, urinary problems, bladder stones, and as a tonic and diuretic (Anderson, 1993) . The independent uses of M. charantia and C occidentalis and other species by many people across such a broad range of geographic regions supports the assumption that bioactive compounds of some value may be present.
Another simple analysis of the data was to look at the distribution of alkaloids and glycosides in relation to mode of application. By considering the primary mode of application (obviously, many medicinals have multiple uses and more than one mode of application), all but nine of the medicinals could be classified. Table 7 shows that most are primarily administered orally; most (75%) such medicines bear bioactive principles. However, most (70%) of those applied topically also bear such substances. Thus, there is no difference (/X/2 = 0.11 l, P = 0.739) in the possible physiological impact of medicinals used in either way. Perhaps one would not expect any such differences because many topical applications are associated with wounds or skin diseases where bioactive compounds get through the skin even without a penetration enhancer.
Overall, baseline alkaloid screening as done in this survey is an important starting point for more detailed investigations of the pharmacological activity of bioactive principles of medicinals. Our resuits and those of others (Farnsworth, 1984a (Farnsworth, , 1984b Schultes, 1986; Cox et al., 1989; Balick, 1990) , show that screening of the ethnobotanical lore of indigenous people provides a rapid and effective means of examining a flora for bioactive compounds. We found that more than 70% of the plant species used by the Garifuna of eastern Nicaragua as medicinals contained alkaloids or glycosides. It is unlikely that a random screening of the local flora would have resulted in such a high success rate. In several studies the percentage of species identified as alkaloid-bearing is considered higher in ethnobotanical screening than would have been found in a random survey (Arthur and Cheung, 1960; Kiang et al., 1961; Amarasingham et al., 1964; Hultin and Torssell, 1965; Farnsworth, 1988) .
What about the remaining 25%-30% of the medicinals that tested negative for alkaloids? Our tests may not have detected alkaloids present, but that seems unlikely. These species may contain other biologically active secondary compounds Table 1 ) is a good source of minerals and vitamins. Of course, not all the medicinals will have either traditional medicinal value or supply the missing nutrients. Some will be valueless, and others of importance psychologically --certain 'prescriptions' provide healing power simply because a respected practitioner in the community prescribed them (just as in Western medicine). Nonetheless, the presence of bioactive compounds in the vast majority of Garifuna medicinals may explain their therapeutic use. These extensive field-based studies are a necessary first step in the search for new biologically active molecules from natural products. Tests to explore the pharmacological activity of the compounds are the required next logical steps in determining the efficacy and application of the Garifuna pharmacopoeia. Table 7 Alkaloids/glycosides and mode of administration (nine species could not be placed in either the oral or the topical category) that together with essential fatty acids, mineral nutrients, and vitamins present, may be of value. Johns (1990) argues that many medicinals are of value not because they are antagonistic to disease organisms, or act as stimulants to organ systems, but because they provide some essential fatty acids, mineral nutrients, or vitamins that are in Another goal of this work has been to document the use of plants in traditional Garifuna culture --a culture that, like many, is disappearing rapidly with acculturation. The next step in that effort is the translation and dissemination of these studies to the Garifuna communities. That effort is underway and, although less sophisticated than the pharmacological trials, is equally important.
